Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Contacts and Locations
No Study Results Posted
Related Studies
Nesiritide in Transplant-Eligible Management of Congestive Heart Failure-TMAC
This study has been terminated.
Study NCT00338455. Last updated on May 15, 2008. Information provided by Scios R&D, Inc.
Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1
Conditions listed in this trial
Renal Insufficiency.
Dialysis
Congestive Heart Failure
Cardiac Transplantation
Renal Failure
2
Additional conditions recognized in this trial
Heart Failure
Kidney Failure
Renal Insufficiency
3
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Kidney Diseases
Urologic Diseases
4
Additional drug interventions recognized in this trial
Dobutamine
Milrinone
Natriuretic Peptide, Brain
5
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic beta-Agonists
Autonomic Agents
Cardiotonic Agents
Cardiovascular Agents
Enzyme Inhibitors
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Phosphodiesterase Inhibitors
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Protective Agents
Sympathomimetics
Therapeutic Uses
Vasodilator Agents
6
Sponsors listed in this trial
Scios R&, Inc.
U.S. National Library of Medicine
,
Contact Help Desk
U.S. National Institutes of Health
,
U.S. Department of Health & Human Services
,
USA.gov
,
Copyright
,
Privacy
,
Accessibility
,
Freedom of Information Act
Links to all studies - primarily for crawlers